澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Medigard Ltd

0.020

0.000

成交量：- -

成交额：- -

市值：344.94万

市盈率：11.89

高：0.020

开：0.020

低：0.020

收：0.020

52周最高：0.020

52周最低：0.020

股本：1.72亿

流通股本：6,055.06万

量比：0.07

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):0.002

每股收益(LYR):0.002

净资产收益率：-38.48%

总资产收益率：-318.93%

市净率：-11.28

市盈率(LYR):11.89

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Medigard Ltd

交易所：

ASX

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.medigard.com.au

邮编：

- -

电话：

- -

传真：

- -

简介：

Medigard Limited operates as a life sciences company in Australia. The company researches and develops medical technologies, including KT009 project to treat degenerative disk disease with an injectable product. Medigard Limited was founded in 1999 and is based in Main Beach, Australia.

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/MGZ.AU/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MGZ.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MGZ.AU\",,,,,undefined,":{"symbol":"MGZ.AU","market":"AU","secType":"STK","nameCN":"Medigard Ltd","latestPrice":0.02,"timestamp":1766466000000,"preClose":0.02,"halted":0,"volume":0,"delay":0,"nameEN":"Medigard Ltd","floatShares":60550612,"shares":172468036,"eps":0.001682,"marketStatus":"未开盘","change":0,"latestTime":"12-23 16:00:00 AEDT","open":0.02,"high":0.02,"low":0.02,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.001682,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1766530800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.02,"openAndCloseTimeList":[[1766444400000,1766466000000]],"volumeRatio":0.071633237781299,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MGZ.AU\",,,,,undefined,":{"symbol":"MGZ.AU","floatShares":60550612,"roa":"-318.93%","roe":"-38.48%","lyrEps":0.001682,"volumeRatio":0.071633237781299,"shares":172468036,"dividePrice":0,"high":0.02,"amplitude":0,"preClose":0.02,"low":0.02,"week52Low":0.02,"pbRate":"-11.28","week52High":0.02,"institutionHeld":0,"latestPrice":0.02,"eps":0.001682,"divideRate":0,"volume":0,"delay":0,"ttmEps":0.001682,"open":0.02,"prevYearClose":0.02,"prevWeekClose":0.02,"prevMonthClose":0.02,"prevQuarterClose":0.02,"fiveDayClose":0.02,"twentyDayClose":0.02,"sixtyDayClose":0.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MGZ.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MGZ.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.medigard.com.au","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0168},{"period":"1month","weight":0.0421},{"period":"3month","weight":0.0657},{"period":"6month","weight":0.1033},{"period":"1year","weight":0.2613},{"period":"ytd","weight":0.2552}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Medigard Limited operates as a life sciences company in Australia. The company researches and develops medical technologies, including KT009 project to treat degenerative disk disease with an injectable product. Medigard Limited was founded in 1999 and is based in Main Beach, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":0.030665},{"month":2,"riseRate":0.1875,"avgChangeRate":0.082611},{"month":3,"riseRate":0.4,"avgChangeRate":0.02443},{"month":4,"riseRate":0.357143,"avgChangeRate":-0.06125},{"month":5,"riseRate":0.266667,"avgChangeRate":-0.044943},{"month":6,"riseRate":0.333333,"avgChangeRate":0.116871},{"month":7,"riseRate":0.214286,"avgChangeRate":-0.001833},{"month":8,"riseRate":0.4,"avgChangeRate":-0.043466},{"month":9,"riseRate":0.466667,"avgChangeRate":0.084216},{"month":10,"riseRate":0.4,"avgChangeRate":0.000752},{"month":11,"riseRate":0.333333,"avgChangeRate":0.052954},{"month":12,"riseRate":0.4,"avgChangeRate":0.07426}],"exchange":"ASX","name":"Medigard Ltd","nameEN":"Medigard Ltd"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"MGZ.AU\",market:\"AU\",,,undefined,":null}}